Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Interest coverage

Interest coverage at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
41.5×+16.1×
Viatris logo
ViatrisVTRS
0.3×+0.1×
Opko Health logo
Opko HealthOPK
-1×-0.4×
AptarGroup logo
AptarGroupATR
8.5×-2.6×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
2.4×+1.4×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
114.2×+46.4×

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

ebit/interest expense=4.5×

Based on trailing twelve months.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's interest coverage?
Amphastar Pharmaceuticals (AMPH) reported interest coverage of 4.5× in Q1 2026.
How has Amphastar Pharmaceuticals's interest coverage changed year-over-year?
Amphastar Pharmaceuticals's interest coverage decreased by 34.8% year-over-year, from 6.9× to 4.5×.
What is the long-term trend for Amphastar Pharmaceuticals's interest coverage?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's interest coverage has grown at a -28.4% compound annual growth rate (CAGR), from 29.3× to 5.5×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.